- Previous Close
16.23 - Open
16.73 - Bid 16.31 x --
- Ask 16.57 x --
- Day's Range
16.06 - 16.73 - 52 Week Range
12.06 - 20.75 - Volume
4,393 - Avg. Volume
31,730 - Market Cap (intraday)
170.531M - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
4.36 - EPS (TTM)
3.78 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gian Life Care Limited provides diagnostic and related healthcare tests and services in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also offers various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.
gianlifecare.orgRecent News: GIANLIFE.BO
View MorePerformance Overview: GIANLIFE.BO
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GIANLIFE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GIANLIFE.BO
View MoreValuation Measures
Market Cap
167.84M
Enterprise Value
138.20M
Trailing P/E
4.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.36
Price/Book (mrq)
1.65
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
2.20
Financial Highlights
Profitability and Income Statement
Profit Margin
31.62%
Return on Assets (ttm)
10.00%
Return on Equity (ttm)
22.22%
Revenue (ttm)
123.23M
Net Income Avi to Common (ttm)
38.96M
Diluted EPS (ttm)
3.78
Balance Sheet and Cash Flow
Total Cash (mrq)
76.78M
Total Debt/Equity (mrq)
24.19%
Levered Free Cash Flow (ttm)
-30.67M